| NCT ID | NCT06574672 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Critical Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,600 participants |
| Start Date | 2024-07-29 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,600 participants in total. It began in 2024-07-29 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to investigate whether embedding a hospice and palliative care practitioner within a medical intensive care unit will improve patient outcomes and healthcare usage. The practitioner will work solely within the medical intensive care units and offer timely as well as proactive consultations based on clinical criteria and estimated mortality risk. The study team will compare patients seen by the practitioner to patients in an adjacent ICU and historical patients to determine whether patient care is improved by this intervention.
Eligibility Criteria
Inclusion Criteria: * Patients admitted to the medical intensive care units at a tertiary referral center * Patients must be at least 18 years of age Exclusion Criteria: * None
Contact & Investigator
Stephen Chi, MD
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT06574672 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06574672 currently recruiting?
Yes, NCT06574672 is actively recruiting participants. Contact the research team at chis@wustl.edu for enrollment information.
Where is the NCT06574672 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT06574672 clinical trial?
NCT06574672 is sponsored by Washington University School of Medicine. The principal investigator is Stephen Chi, MD at Washington University School of Medicine. The trial plans to enroll 2,600 participants.